Investments

News & Insights

About Us

Contact Us

Top Banner

News and Insights

Insights to Keep You Ahead of the Market

Latest News

Our daily experts on 'the call' give their buy, hold or sell recommendation on a stock or sector in the news today.

Stock of the day: Neuren Pharmaceuticals (NEU)

Stock of the Day

Stock of the day: Neuren Pharmaceuticals (NEU)

14 Jan 2026

Buy, Hold, or Sell? Get the verdict on Neuren Pharmaceuticals (NEU) from our experts, Michael Gable from Fairmont Equiti...

metals momentum

Market Wrap

metals momentum

14 Jan 2026

The Australian sharemarket recovered from earlier losses today, despite a major selloff in the banks which saw heavyweig...

Stock of the day: Endeavour (EDV)

Stock of the Day

Stock of the day: Endeavour (EDV)

13 Jan 2026

Buy, Hold, or Sell? Get the verdict on Endeavour (EDV) from our experts, Rudi Filapek-Vandyck from FNArena and Sanjee Na...

Stock of the day: Super Retail (SUL)

Stock of the Day

Stock of the day: Super Retail (SUL)

12 Jan 2026

Buy, Hold, or Sell? Get the verdict on Super Retail (SUL) from our experts, Mathan Somasundaram from Deep Data Analytics...

Stock of the day: Rio Tinto (RIO)

Stock of the Day

Stock of the day: Rio Tinto (RIO)

09 Jan 2026

Buy, Hold, or Sell? Get the verdict on Rio Tinto (RIO) from our experts, Adam Dawes from Shaw and Partners and Jun Bei L...

Stock of the day: BlueScope (BSL)

Stock of the Day

Stock of the day: BlueScope (BSL)

08 Jan 2026

Buy, Hold, or Sell? Get the verdict on BlueScope (BSL) from our experts, David Novac from Wealthwise Education and Howar...

Ausbiz Company Interviews

Company leaders share their vision, growth strategy, and why their stock deserves your attention.
Neuren boosted by favourable sales forecast

Company Interview

Neuren boosted by favourable sales forecast

14 Jan 2026

Key points:

Neuren Pharmaceuticals (ASX:NEU) projects US$700 million in Daybue sales by 2028Launch of Daybue Stix aims to...

Kickstarting the kava market

Company Interview

Kickstarting the kava market

14 Jan 2026

Key Points:

Record December revenue driven by regulatory clarity and wholesale demandExpansion into higher potency kava p...

ECS's high on cash and planning more B2C

Company Interview

ECS's high on cash and planning more B2C

14 Jan 2026

Key points:

ECS Botanics (ASX:ECS) reports cash flow positive quarter and 43% share price risePivot to B2C and in-house b...

The small cap following the lithium momentum

Company Interview

The small cap following the lithium momentum

14 Jan 2026

Key points:

Neometals (ASX:NMT) announces three-year ELi process collaboration with De NoraPiloting with Rio Tinto (ASX:R...

Ausbiz TV Stock of the Day

Our daily experts on 'the call' give their buy, hold or sell recommendation on a stock or sector in the news today.

Stock of the day: Neuren Pharmaceuticals (NEU)

Stock of the day: Neuren Pharmaceuticals (NEU)

14 Jan 2026

Buy, Hold, or Sell? Get the verdict on Neuren Pharmaceuticals (NEU) from our experts, Michael Gable from Fairmont Equiti...

Stock of the day: Endeavour (EDV)

Stock of the day: Endeavour (EDV)

13 Jan 2026

Buy, Hold, or Sell? Get the verdict on Endeavour (EDV) from our experts, Rudi Filapek-Vandyck from FNArena and Sanjee Na...

Stock of the day: Super Retail (SUL)

Stock of the day: Super Retail (SUL)

12 Jan 2026

Buy, Hold, or Sell? Get the verdict on Super Retail (SUL) from our experts, Mathan Somasundaram from Deep Data Analytics...

Stock of the day: Rio Tinto (RIO)

Stock of the day: Rio Tinto (RIO)

09 Jan 2026

Buy, Hold, or Sell? Get the verdict on Rio Tinto (RIO) from our experts, Adam Dawes from Shaw and Partners and Jun Bei L...

3 simple steps to investing with us
01

REGISTER WITH US

Create your account quickly and easily by filling out our online registration form. Once registered, you'll be ready to explore your investment options.

02

Speak with a team member

One of our experienced team members will reach out to you to understand your investment interests and provide information based on your goals.

03

Investment Information

We supply all the relevant information, including market insights and reports, to help you make informed investment decisions and take the next steps with confidence.

Register to start Investing with us

Our frienly staff will be in touch with you shortly to help you get started with us.

What is a 708 investor?

By clicking submit, I agree to the terms of the Ausbiz Capital Privacy Policy.

Copyright © 2026 Ausbiz Capital